Haydn T. Kissick, PhD
Senior Research Associate in Tumor Immunology, Division of Translational Research, Department of Urology, Emory University School of Medicine
Dr. Kissick is a Senior Research Associate in Tumor Immunology in the Division of Translational Research at Emory Urology and the Emory Vaccine Center. He received his PhD in immunology from the University of Western Australia, and completed his postdoctoral fellowship in prostate cancer immunology at Harvard Medical School.
Dr. Kissick's research focuses on developing next generation sequencing capable of identifying mutations to be used in personalized vaccine targets for prostate cancer. Having used these techniques in mouse models to identify novel vaccine candidates targeting mutations, Dr. Kissick and his colleagues have found that the immune system responds effectively against these mutations. They are now evaluating vaccines targeting mutations in prostate cancer patients as personalized immunotherapeutic vaccines. He is also interested in characterizing how the immune response to cancer is impaired by inducing exhaustion in tumor-specific CD8 T-cells, and therapies to overcome this.
View Dr. Kissick's publications in PubMed.
BSc in Microbiology and Immunology, University of Western Australia, Perth, 2006
PhD in Tumor Immunology, University of Western Australia, Perth, 2007-2011
Fellowship in Prostate Cancer Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, 2011-2014
Honors and Awards
Young Investigator Award, Prostate Cancer Foundation, 2014
Postdoctoral Fellowship Award, Department of Defense Prostate Cancer Program, 2013
Development of next generation sequencing capable of identifying mutations to be used in personalized vaccine targets for prostate cancer